Recently, Wu et al. have found that tumor-derived succinate could trigger SUCNR1-PI3K-hypoxia-inducible factor 1 alpha (HIF-1 alpha) axis to polarize macrophages into anti-inflammatory phenotype, which accelerates tumor progression in vitro and in vivo studies [217]. The gene discussed is SUCNR1; the disease is neoplasm.